Latest Asx News

Metallium Ltd has appointed former U.S. Deputy Assistant Secretary of Defense Travis Langster to its U.S. advisory board, aiming to strengthen ties with government and industry for critical metals supply chain resilience.

Core Lithium has launched a $10 million Share Purchase Plan offering eligible shareholders the chance to buy new shares at the same price as a recent institutional placement, aiming to bolster working capital and support key project developments.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Iress Limited has appointed Andrew Russell as its new Group CEO, marking a strategic leadership shift following a major company transformation. Russell’s extensive fintech experience positions him to lead Iress into a product and client-focused future.

Traka Resources has extended the option period for the Mt Cattlin Gold Project sale, securing a revised deal with potential upside, while stepping away from the Didi Gold Project to sharpen its focus on core assets.

Control Bionics Limited has announced a 1-for-5 non-renounceable rights issue to raise up to $2.06 million, aiming to fund the commercial expansion of its NeuroStrip® device and operational growth. The offer is partially underwritten and open to eligible shareholders in Australia and New Zealand.

Provaris Energy has formalized a strategic collaboration with Baker Hughes to advance compressed hydrogen solutions for marine transport and storage across Europe, marking a key milestone in scaling regional hydrogen supply chains.

Haranga Resources has successfully commissioned the water treatment plant at its Lincoln Gold Project and begun dewatering, paving the way for its maiden underground drilling program and a JORC resource update by year-end.

Tali Resources has completed its initial reverse circulation drilling program at the West Arunta Project, with assay results expected in the December quarter. The company is advancing further exploration activities backed by government incentives.

Moho Resources has significantly expanded its Bush Chook Gold Project in Western Australia’s Pilbara Craton, acquiring nine new tenements that reveal multiple high-grade gold zones yet to be drill tested.

Amplia Therapeutics has commenced dosing the first patient in its new pancreatic cancer trial combining narmafotinib with FOLFIRINOX chemotherapy, marking a key milestone in its drug development journey.

Ora Banda Mining reports exceptional drill results from the Waihi deposit, revealing a new gold lode and significant depth extensions that strengthen the case for a third underground mine at the Davyhurst Project.